Article

Development and validation of an HPLC-UV method for the determination of gatifloxacin in bulk material, pharmaceutical formulations, human plasma and metal complexes.

Research Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi.
Pakistan journal of pharmaceutical sciences (Impact Factor: 0.95). 11/2006; 19(4):275-81.
Source: PubMed

ABSTRACT A simple reversed phase HPLC method was developed for the quantitative determination of gatifloxacin (GTX) in the bulk material, pharmaceutical formulations and human serum using Mediterranea C18 (25 x 0.46 mm, 5 mm) column. The mobile phase, acetonitrile, methanol and water (40:40:20 v/v pH 2.7 adjusted by phosphoric acid), was delivered at a flow rate of 1.0 ml/min. The eluent was monitored using spectrophotometric detection at 286 nm. The method is specific to GTX and able to resolve the drug peak from formulation excipients and metal impurities. The method is accurate (99.18-101.87%), precise (intra-day variation 0.14-1.67% and inter-day variation 0.32-1.80%) and linear within the range 0.1-25 microg/ml (R2=0.999) concentration and was successfully used in monitoring left over drug in drug-metal complexes. The detection limit of GTX at a signal-to-noise ratio of 3 was 1.73 ng/ml in human plasma while quantification limit in human serum was 5.77 ng/ml. The proposed method is applicable to routine analysis of GTX in pharmaceutical formulations as well as in human plasma samples.

Download full-text

Full-text

Available from: Najma Sultana, Aug 10, 2015
1 Follower
 · 
554 Views
  • Source
    • "Gatifloxacin was assayed in plasma by reversephase high performance liquid chromatography (HPLC), using a reported assay with minor modifications (Najma Sultana et al., 2006; Santoro et al., 2006). The HPLC system (Laballiance, USA) comprised a quaternary gradient solvent delivery pump (model AIS 2000) and UV detector (model 500). "
    [Show abstract] [Hide abstract]
    ABSTRACT: 1. The pharmacokinetics of gatifloxacin were investigated following intravenous and oral administration of a single dose at a rate of 10 mg/kg body weight in broiler chicks. 2. Drug concentration in plasma was determined using High Performance Liquid Chromatography with ultraviolet detection on samples collected at frequent intervals after drug administration. 3. Following intravenous administration, the drug was rapidly distributed (t(1/2α): 0·33 ± 0·008 h) and eliminated (t(1/2β): 3·62 ± 0·03 h; Cl(B): 0·48 ± 0·002 l/h/kg) from the body. 4. After oral administration, the drug was rapidly absorbed (C (max): 1·74 ± 0·024 µg/mL; T (max): 2 h) and slowly eliminated (t(1/2β): 3·81 ± 0·07 h) from the body. The apparent volume of distribution (V(d(area))), total body clearance (Cl(B)) and mean residence time (MRT) were 3·61 ± 0·04 l/kg, 0·66 ± 0·01 l/h/kg and 7·16 ± 0·08 h, respectively. The oral bioavailability of gatifloxacin was 72·96 ± 1·10 %. 5. Oral administration of gatifloxacin at 10 mg/kg is likely to be highly efficacious against susceptible bacteria in broiler chickens.
    British Poultry Science 04/2012; 53(2):257-61. DOI:10.1080/00071668.2012.682724 · 0.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin® for the treatment of respiratory tract infections..
    Profiles of Drug Substances, Excipients and Related Methodology 01/2012; 37:183-243. DOI:10.1016/B978-0-12-397220-0.00005-2
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fluoroquinolones are one of the most promising and intensively studied drugs of contemporary anti-infective chemotherapy. New fluoroquinolone antibacterials with improved pharmacokinetic properties and a broad spectrum of activity have been developed, opening new windows of opportunity for clinical use. To our knowledge, no comprehensive and critical review of the analytical methods for the determination of these agents, which correspond to the third- and fourth-generation quinolones, has yet been published. This work summarizes for the first time most of the liquid chromatographic methods reported in the literature for the separation and quantification of the new fluoroquinolones in biological matrices and pharmaceutical formulations. A systematic and detailed survey of physicochemical properties, sample preparation procedures, and chromatographic and detection conditions is presented herein. In the course of this review several liquid chromatographic methods are discussed: reversed-phase high-performance liquid chromatography (RP-HPLC), ion-exchange high-performance liquid chromatography (IEX-HPLC), hydrophilic interaction liquid chromatography (HILIC), high-performance thin-layer chromatography (HPTLC) and other chiral chromatographic methods. Their advantages, applicability and limitations are also examined.
    Analytical and Bioanalytical Chemistry 02/2012; 403(1):93-129. DOI:10.1007/s00216-011-5706-8 · 3.58 Impact Factor